March 23, 2009
Pharmacosmos participates in the World Congress of Nephrology
2009. The WCN is held in Milan, Italy during the period May 22nd to
26th, 2009. The WCN 2009 is a joint meeting with ERA-EDTA (European
Renal Association - European Dialysis and Transplant Association)
and ISN (International Society of Nephrology).
About Pharmacosmos A/S
Pharmacosmos develops and markets
medicines for the treatment of iron deficiency. A research-based
company, its ongoing R&D programme focuses on improving the
treatment options for healthcare professionals and patients
suffering from iron deficiency.
Pharmacosmos is a privately-owned
Danish company and operates in more than 50 countries across
Europe, the Americas and Asia. Its facilities are approved by the
Danish Medicines Agency and the US Food & Drug
Administration.